Question

A 62-year-old with HFrEF (LVEF 30%) is on an ACE inhibitor, evidence-based beta-blocker, and spironolactone. eGFR 70 mL/min/1.73 m², K⁺ 4.5 mEq/L. What additional disease-modifying therapy should be initiated now?

Accepted Answer

Dapagliflozin 10 mg daily

Answer

Hydralazine monotherapy

Answer

Ivabradine

Answer

Digoxin

Answer

Loop diuretic escalation

Practice question

A 62-year-old with HFrEF (LVEF 30%) is on an ACE inhibitor, evidence-based beta-blocker, and spironolactone. eGFR 70 mL/min/1.73 m², K⁺ 4.5 mEq/L. What additional disease-modifying therapy should be initiated now?